Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GABRP | O00591 | 2/20 | 0.34 |
| ▸ | GABRD | O14764 | 2/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.34 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.34 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.34 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.34 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.34 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.34 |
| ▸ | GABRE | P78334 | 2/20 | 0.34 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.34 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1964906 | 1.00 | SLC22A6 (0.36) | SLC22A6GABRR1LMNAS1PR2S1PR1 | |
| SCHEMBL288405 | 1.00 | SLC22A6 (0.36) | SLC22A6GABRR1LMNAS1PR2S1PR1 | |
| SCHEMBL19918393 | 0.82 | GABRR1 (0.33) | SLC22A6GABRR1LMNAS1PR2S1PR1 | |
| SCHEMBL19918389 | 0.82 | GABRR1 (0.33) | SLC22A6GABRR1LMNAS1PR2S1PR1 | |
| SCHEMBL3962591 | 0.80 | S1PR2 (0.36) | SLC22A6GABRR1LMNAS1PR2S1PR1 | |
| SCHEMBL27186030 | 0.80 | S1PR2 (0.36) | SLC22A6GABRR1LMNAS1PR2S1PR1 | |
| SCHEMBL3995049 | 0.80 | GABRP (0.35) | SLC22A6GABRR1LMNAS1PR2S1PR1 | |
| SCHEMBL3995651 | 0.80 | GABRP (0.35) | SLC22A6GABRR1LMNAS1PR2S1PR1 | |
| SCHEMBL28754981 | 0.80 | S1PR2 (0.36) | SLC22A6GABRR1LMNAS1PR2S1PR1 | |
| SCHEMBL3962147 | 0.79 | CACNA2D1 (0.38) | SLC22A6GABRR1LMNAS1PR2S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240109937-A1 | BINDING PEPTIDES AND USES THEREOF | THE JOHNS HOPKINS UNIVERSITY | 2024-04-04 | — | — | US | claimed |
| WO-2022170196-A1 | BINDING PEPTIDES AND USES THEREOF | THE JOHNS HOPKINS UNIVERSITY (US) | 2022-08-11 | — | — | WO | claimed |
| US-20240109937-A1 | BINDING PEPTIDES AND USES THEREOF | THE JOHNS HOPKINS UNIVERSITY | 2024-04-04 | — | — | US | disclosed |
| WO-2022170196-A1 | BINDING PEPTIDES AND USES THEREOF | THE JOHNS HOPKINS UNIVERSITY (US) | 2022-08-11 | — | — | WO | disclosed |
| CN-104284891-B | Conformationally constrained, fully synthetic macrocyclic compounds | 波利弗尔股份公司 | 2018-04-17 | — | — | CN | disclosed |
| US-6903233-B2 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-06-07 | — | — | US | disclosed |
| US-20030225301-A1 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-12-04 | — | — | US | disclosed |
| EP-1344763-A1 | Process for producing optically active 3-halogenocarboxylic acid esters and 3-azide-carboxylic acid esters | Takasago International Corporation (JP) | 2003-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225301-A1 | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester | HDHD5, APEH, AOC3 | SLC22A6 1264/4885GABRR1 3460/4885LMNA 3776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.